تحليل ما قبل جلسه 11 اغسطس 2026

Presenter / Source

• Mustafa Rafat — Head of Technical Analysis, Astoool Securities and Bond Brokerage Company

---

Market / Index (Technical Outlook)

EGX 30

• Yesterday close: down ~249 points to around 54,870

  Note: The subtitle text contains a conflicting “876 points”; the main referenced level is ~54,870.

• Trend view: still in a general upward trend (short + medium term), conditionally.

Key conditions / levels

• Nearest minor support levels to hold:

  • 54,500
  • ~54,000 (referenced as the “best portfolio” area in the short term)

• If either level breaks: outlook shifts from uptrend to sideways

  • Suggests switching from “hold” to “active trading.”

Trade framework (when support breaks / risk increases)

• Instead of telling you to hold:
  • Buy near support levels
  • Sell at resistance levels

Targets

• Initial target: 55,500
• Next short-term target (after 55,500): 57,000

Risk management

• Emphasizes raising profit-protection levels after sharp rises.

---

EGX 70

• Described as stronger than EGX 30/100
  • On a strong upward trajectory
  • With a “dominant market leader”

Profit-protection (minor support) levels

• Around 20,600
• Then 20,508

  Note: Subtitle text is messy; these are the two cited levels.

Targets

• 21,500
• 22,000

Caution

• Profit-taking may occur, but expected to be within 1–2 sessions.

---

EGX 100

• Yesterday close: 27,521

New targets (medium term)

• Initial: 28,500
• Main: 30,000

Profit-protection / nearest minor support

• 26,700

• Positive bias as long as price stays above these protection levels.

---

Sector Calls & Stock Recommendations (with Levels)

Healthcare Sector (Top Performing)

General stance: sector is leading with price surges across most stocks (not all).

Nile Pharmaceuticals

• Yesterday close / peak: 430.80 EGP
• Noted event: “cleared the 20% price drop”
• Main target: 450 EGP
• Important caution / recommendation change:
  • Author says not to open new targets yet
  • Does not advise new entries because the stock has risen “too much” → riskier setup
• Profit-protection / closest level: around 360 EGP

  Stated as ~20% away

Arab Pharmaceuticals

• Yesterday close: 341 EGP
• Target: 350–352 EGP
• New round target today: 370 EGP
• Profit-protection / minor support: 323 EGP
• Maintains an overall upward trend.

Manfas Pharmaceuticals

Subtitle contains conflicting numbers (likely OCR), but the key levels are as follows.

• Implied trajectory / targets:

  • “Most likely” 393 EGP
  • Then 420 and 440 EGP (initial targets, “God willing”)

• Risk note: high-risk short-term, with support “very far away”

• Nearest secondary support cited: 342 or 350 EGP
• Claimed close: “303 (or rather, 393 EGP)”

  Note: inconsistency present in the source text.

EIPICO (appears as EPICO / EIPICO)

• Yesterday close: 160.18 EGP
• Setup: new buying after breaking above 140–142 EGP
• Targets: 170, then 185 EGP
• Profit-protection / minor support: 143–145 EGP

Tenth of Ramadan Pharmaceutical Industries (“Ramidah”)

• Yesterday close: 6.94 EGP
• Continuation condition: if above 6.45 EGP (and raise protection)
• Profit-protection raised to: 6.70 EGP
• Targets: 7.25 EGP, then 7.50 EGP (“God willing”)

Sabq for Pharmaceuticals

• Yesterday close / cited support: 5.11 EGP
• Profit-protection / nearest minor support: 4.86 EGP

• Targets: around 5.35

  Note: subtitle says “35 EGP level” — likely 5.35

• Then 5.50 EGP

---

Food, Beverage, and Tobacco Sector

Ismailia Poultry

• Level broken: 33.30 EGP
• Outlook: likely to break higher
• Targets: 34–35 EGP
• Profit protection / support to raise to: 32 EGP

  Note: subtitle text is corrupted (“32 or 16”), but the conditional is explicitly “above 32 EGP”.

---

Real Estate Sector

Amer Group

• Yesterday close: 6.48 EGP

• Targets: 6.86 EGP then 7.00 EGP

  Note: subtitle text is inconsistent; “86” appears to be 6.86.

• Hold condition (short/medium term):

  • Hold as long as above 5.75–5.80 EGP
• Nearest minor support: 6.25 EGP

SODIC (6th of October)

• Yesterday close: 1.31 EGP

  Note: subtitle contains conflicting “29.70 EGP…” values, likely a transcription/OCR error.

• Setup: “new buy signal” after closing around the cited level

• Targets: 33.50 EGP, then 35 EGP

  Note: likely OCR mismatch in the original; numbers appear inconsistent with the stated close.

• Profit protection raised to: 29.70 EGP (explicit number given)

Al Ahli for Development

• Yesterday close: 64.90 EGP
• Targets: 70–72 EGP
• Profit protection raised to nearest minor support: 60.50 EGP

HIBEC0 Investments (High Risk)

• Risk warning: extremely high volatility, violent fluctuations, and low trading volume
• Trade sizing / recommendation:
  • No new buy positions except very small portions for speculative, risk-taking investors
  • Conservative / short-term investors: “stay away completely”
• Support / levels:
  • Nearest minor support: 12.45–12.46 EGP
  • Highest supports: 13.5 then 15 EGP
• Activity mentioned: executed trades totaling ~19 million EGP

  Context: “Yesterday, we executed all our trades…”

---

Methodology / Framework Explicitly Used

• Index conditional trend rules (EGX 30):

  • Maintain upward trend only while above nearest minor support, notably 54,500 (with references around 54,000).
  • If support breaks → shift bias to uptrend-to-sideways.

• Execution guidance when risk increases:

  • Replace “hold” with trading at levels:
    • Buy at support
    • Sell at resistance

• Profit protection / risk management:

  • After sharp rises, raise profit-protection levels to the nearest minor support in each index/stock to avoid getting “trapped” in a correction.

---

Disclosures / Disclaimers

• Important Disclaimer (verbatim meaning):
  • Prepared based on information believed accurate/reliable.
  • Company and author are not legally responsible for any investment decisions made based on the report (buy/sell).

---

Tickers / Instruments / Indices Mentioned

Indices

• EGX 30
• EGX 70
• EGX 100

Stocks

• Odin Investments
• Nile Pharmaceuticals
• Arab Pharmaceuticals
• Manfas Pharmaceuticals
• EIPICO (EPICO in subtitle)
• Tenth of Ramadan Pharmaceutical Industries (Ramidah)
• Sabq for Pharmaceuticals
• Ismailia Poultry
• Amer Group
• SODIC
• Al Ahli for Development
• HIBECO Investments

Sectors

• Healthcare
• Food & Beverage & Tobacco
• Real Estate

Currency

• EGP (Egyptian pounds)